Stay updated on KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Difference
    0.2%
    Check dated 2025-03-25T13:37:54.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-03-11T04:10:57.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-03-03T23:10:49.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T20:22:50.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-02-17T14:26:00.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    2%
    Check dated 2025-02-10T09:33:27.000Z thumbnail image

Stay in the know with updates to KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial page.